bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
Published 4 years ago • 140 plays • Length 1:32
Download video MP4
Download video MP3
Similar videos
-
1:01
oliver sartor, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
-
0:47
tom beer, md on the data presented at asco gu20 investigating atezolizumab and cabozantinib in mcrpc
-
1:14
dr. mcgregor on the combination of atezolizumab and bevacizumab in rcc
-
0:37
tanya dorff, md, elaborates on data investigating atezolizumab and cabozantinib in prostate cancer
-
1:16
bradley mcgregor, md, on the data regarding enfortumab in post-platinum i-o bladder cancer
-
2:09
bradley mcgregor, md, considers the optimal approach to treating newly diagnosed rcc patients
-
1:10
daniel petrylak, md, on investigating atezolizumab and cabozantinib relating to prostate cancer
-
0:59
dr. mcgregor on future research in mcrpc
-
2:16
dr. mcgregor on data evaluating the link between cardiac complications and adt in prostate cancer
-
2:10
esmo23: brad mcgregor, md | dana-farber cancer institute
-
0:45
do biologic dmards increase the risk of cancer?
-
0:32
trial finds most effective prostate cancer therapy
-
1:49
dr. mcgregor on immunotherapy combinations in kidney cancer
-
2:06
dr. mcgregor on whether patients need frontline combinations in rcc
-
1:22
copy of dr. mcgregor on implications of the fda approval of pembrolizumab/axitinib in rcc
-
1:54
dr. mcgregor on immunotherapy in rare genitourinary cancers
-
1:08:21
finding your voice in prostate cancer | live talk
-
6:35
esmo 2019: dr. mcgregor highlights impactful 2019 prostate cancer studies
-
1:41
dr. posadas discusses cabozantinib in prostate cancer
Clip.africa.com - Privacy-policy